Wilmington PharmaTech Company LLC Email Format
Pharmaceutical ManufacturingDelaware, United States11-50 Employees
Wilmington PharmaTech Company LLC is a U.S.-based contract research, development, and manufacturing organization that focuses on complex small-molecule APIs. The company serves the pharmaceutical and biotechnology industries by offering services across the research and development spectrum, including custom synthesis, process chemistry, medicinal chemistry, API manufacturing, and analytical support, supported by capabilities such as polymorph screening and salt selection. Its operations are anchored in the United States and China, with a facility footprint in Newark, Delaware, and a history dating back to 2003, reflecting a long-standing emphasis on quality and reliability in R&D and manufacturing for drug development. The target market comprises pharma and biotech companies seeking specialized, end-to-end small-molecule API development and production capabilities, particularly in areas requiring advanced chemistry and cGMP-compliant manufacturing. A notable recent development is the company’s announced expansion of its Delaware campus to increase API reactor capacity, signaling ongoing investment to meet growing demand for U.S.-based, high-quality manufacturing.